The Researcher Who Never Was: Sequestration Blues-Part One

New Orleans, March 1, 2013: Barges on the Mississippi still moving on Sequestration Day. New Orleans, March 1, 2013: Barges on the Mississippi still moving on Sequestration Day. Photo courtesy of author.

So it happened. I woke up on March 1 in a hotel room in New Orleans, and everything was eerily quiet. Outside, it was the usual silent rush hour of barges, slowly being pushed up the Mississippi River. Inside, there was only the occasional slammed door down the hallway, probably an unfortunate hotel guest who needed to catch an early flight. Despite the arrival of the draconian automatic government spending cuts known as sequestration, the rotation of the earth had not come to a grinding halt.

So, business as usual? Not at all. We will look back at this March 1, 2013, as a very bad day for science policy in the United States and we will deeply regret it. The risk, as I see it, is that many citizens will feel exactly as I did waking up in the Crescent City, and realizing that the world had not come to a stop, deciding that nothing has happened. Not yet. Sequestration was designed to be so awful that it could not happen, showing that sometimes reality can be more creative than imagination. As several economists and policy analysts have pointed out, sequestration will not bite immediately. It will take a while, perhaps too long for a society with a very short attention span, to sink its teeth into our future. And this is particularly true for the effect on science, engineering, and innovation.

Science is about long distance running, not the 100-meter dash. Science runs on cycles far longer than election cycles because the direct product of science is knowledge, not services. It can take decades to grasp the relevance of a new fact or insight. PCR was invented to help scientists settle obscure questions about nucleic acids. No one imagined that it would be used in criminal trials, to track human evolution, or to find DNA traces of horse meat in frozen "beef" hamburgers. I also think of the legendary advocate for basic medical research, Mary Lasker. She said it best—if you think research is expensive, try disease!

To me, sequestration is nonsense. Imagine if the federal government were a corporation that suddenly could not afford to sustain its expenses. The good CEO would not say to cut everything linearly. The visionary leader would instead make bigger cuts in areas that were either not as productive as competitors' or too mature for real growth. Smart leaders would increase some areas of R&D funding, yes, even during austerity times, in promising areas. It is innovation, not lack thereof, which will get us out of the hole. Many advanced and developing nations, especially in Asia, are ramping up their investments in science and technology, because they understand this is about their future. Consider that between 1995 and 2007, China increased its scientific publications by 16%; Singapore by more than 10%. The United States? Less than 0.5%. In short, we are eating our seed corn. And now with sequestration, we must throw away 5% of that.

Science, and particularly basic science, has been phenomenally successful in the improvement of health. Think of the decrease in mortality due to the reduction in cardiovascular mortality. Those improvements alone are responsible for about 70% of increased life expectancy. Think how relatively quickly we transformed HIV/AIDS from a death sentence into a manageable chronic disease.

Should we be satisfied now, and call it a day? We probably understand 5% of human biology. And I do not think this is an exaggeration. Think of how intractable most mental health disorders remain. We understand so little about the brain and about mental illness, which is why we have so few effective therapeutics. The price we pay for extended life expectancy is the rise of chronic debilitating disease. We need to tackle disorders like Alzheimer's or Parkinson's not merely so we can live longer but so we can live longer productively. The economic and societal impacts of our relative ignorance about these and other biological mysteries are huge. A 2011 report from the World Economic Forum estimated that over the next 20 years, chronic diseases (mostly mental disorders, Parkinson's, and Alzheimer's) will cost more than US $30 trillion. In 2010 that figure represented 48% of global GDP. By 2030, these costs will push millions of people below the poverty line.1

Research is an imperative, because research is hope; without research we are robbed of our future and flattened into the present. Is this what we want?

Sequestration and anemic investments in research, lost funding—and lost time—could cost us the next big breakthrough in science and sidetrack important incremental advances, which are essential to new fields. I cringe at the delayed cures and the unexplored connections that will be the price of these myopic policies, but what worries me the most is that of losing talent, human talent, young human talent. We run the risk of losing the next generation of scientists, as the former NIH Director, Dr. Elias Zerhouni, recently pointed out.2

This is the biggest risk that we are facing and it leads me to some slightly more in depth considerations on the biomedical workforce. In facing these extraordinary challenges, I wonder how we can keep attracting young and enthusiastic students into science, while at the same time responsibly worrying if there are enough opportunities for them. I think these are very probing issues, exacerbated by the latest nonsensical sequestration cuts. All of us in research biology, at the ASCB and elsewhere, should seriously focus on this issue and ask ourselves a very tough question—do we really need more biomedical scientists?

I will tackle that issue in the next installment of "Activation Energy: The Researcher Who Never Was:Sequestration Blues—Part Two'

  1. Bloom DE et al. (2011). The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum.
  2. http://www.washingtonpost.com/blogs/wonkblog/wp/2013/02/21/former-nih-director-the-sequester-will-set-back-medical-science-for-a-generation/
Stefano Bertuzzi

Dr. Stefano Bertuzzi is the Executive Director of the American Society for Cell Biology. In this position he is responsible, with the ASCB Board, for strategic planning and all operations at the Society to serve the needs of its ~9,000 members and to promote the field of cellular biology and basic science.

Email This email address is being protected from spambots. You need JavaScript enabled to view it.

Most Recent Articles *

To read the full article, click on the READ MORE button below.

  • 1
  • 2
  • 3
  • 4
Prev Next
ASCB Kaluza Prize Reflects ASCB’s Concern that Young Scientists Are Now a Vulnerable Population

ASCB Kaluza Prize Reflects ASCB’s Concern that Young Scientists Are Now a Vulnerable Population

The ASCB Kaluza Prize recognizes significant research achievement by early career scientists who still pursue excellence amidst economic uncertainties and political shortsightedness. ASCB Photo.In the...

11-20-2013

Read more
Round Trip from Stockholm to ASCB

Round Trip from Stockholm to ASCB

With Stockholm still in the future, Randy Schekman (third from left) with fellow 2013 Nobel winner, Jim Rothman (far right), shared the ASCB's highest scientific honor, the E. B. Wilson Medal, with St...

11-06-2013

Read more
Colliding Worlds—A Rare Visit to the CERN Collider Gives a Biologist New Hope

Colliding Worlds—A Rare Visit to the CERN Collider Gives a Biologist New Hope

Nearly 170 meters beneath CERN, ASCB Executive Director Stefano Bertuzzi gets a rare look at the Large Hadron Collider. Here he stands in front of the detector. Photo Credit: ASCBLast week, I was invi...

10-23-2013

Read more
Watching Train Wrecks

Watching Train Wrecks

It’s full steam ahead for disaster or will the brakes stop the runaway fiscal crisis train in time? Photo by John FleischmanAlong with the future of U.S. research science, the train wreck metaphor has...

10-16-2013

Read more
UPDATED-NIH Furloughs to Widen—From Slowdown to Shutdown, U.S. Science Takes a Hit

UPDATED-NIH Furloughs to Widen—From Slowdown to Shutdown, U.S. Science Takes a Hit

The USDA is closed and no U.S. orders for international fruit flies can be processed until the government is back in business.Photo Credit: André KarwathUUPDATED—The "Activation Energy" blog has learn...

10-09-2013

Read more
Shutting Down Basic Science—Some Thoughts at Midnight (no, this is not a fairy tale)

Shutting Down Basic Science—Some Thoughts at Midnight (no, this is not a fairy tale)

Last night at midnight, the government ran out of money and shut down its main operations. Sadly, it left me wondering if perhaps our democracy ran out of steam as well. I've tried to explain what is ...

10-01-2013

Read more
New Partners and New Ventures for ASCB in Science Education Reform

New Partners and New Ventures for ASCB in Science Education Reform

In a 2012 Science editorial, Bruce Alberts, a former ASCB president who was then the journal's editor, urged professional societies to team up in leading innovation in science education. ASC...

09-25-2013

Read more
The Scholarly Paper That No One Will Want to Read Is Being Written in Congress

The Scholarly Paper That No One Will Want to Read Is Being Written in Congress

Spelling It Out: Spending on basic research has increased our longevity and the quality of that longer life. Photo Credit: John FleischmanThis week, a paper in the American Journal of Public Health, a...

09-18-2013

Read more
A Scientist-Senator with a Seat — and a Vote — for Life

A Scientist-Senator with a Seat — and a Vote — for Life

I recently spent some time on a family vacation in Italy. We have a tradition in our family; at the dinner table, each of us has to say the best and the worst thing that happened to him or her during ...

09-10-2013

Read more
Showing the Faces of Science

Showing the Faces of Science

In 2011, the Nobel Foundation awarded its prize of prizes to cell biologist, immunologist, and longtime ASCB member Ralph Steinman. When the foundation tried calling to deliver the good news, no one p...

09-05-2013

Read more
Lessons from a Society of Societies

Lessons from a Society of Societies

This week, ASCB went to ASAE, or rather five ASCB staffers and yours truly attended a meeting of the ASAE in Atlanta. ASCB, I trust you know, stands for the American Society for Cell Biology. The ASAE...

08-07-2013

Read more
Why Congress Should Be Worried About the Endoplasmic Reticulum

Why Congress Should Be Worried About the Endoplasmic Reticulum

Morphogenesis in biology always fascinated me. As a developmental neurobiologist at the bench, I studied how homeobox genes patterned the neural epithelium, the retina in particular, to understand the...

07-30-2013

Read more